journal article·2020-09-16

Maximizing Magnetic Resonance Contrast in Gd(III) Nanoconjugates: Investigation of Proton Relaxation in Zirconium Metal–Organic Frameworks

Shaunna M. McLeod, Lee Robison, Giacomo Parigi, Alyssa Olszewski, Riki J. Drout, Xinyi Gong, Timur Islamoglu, Claudio Luchinat, Omar K. Farha, Thomas J. Meade

ACS Applied Materials & Interfaces· Volume 12· Issue 37
Publisher page

Abstract

Gadolinium(III) nanoconjugate contrast agents (CAs) provide significant advantages over small-molecule complexes for magnetic resonance imaging (MRI), namely increased Gd(III) payload and enhanced proton relaxation efficiency (relaxivity, r1). Previous research has demonstrated that both the structure and surface chemistry of the nanomaterial substantially influence contrast. We hypothesized that inserting Gd(III) complexes in the pores of a metal–organic framework (MOF) might offer a unique strategy to further explore the parameters of nanomaterial structure and composition, which influence relaxivity. Herein, we postsynthetically incorporate Gd(III) complexes into Zr-MOFs using solvent-assisted ligand incorporation (SALI). Through the study of Zr-based MOFs, NU-1000 (nano and micronsize particles) and NU-901, we investigated the impact of particle size and pore shape on proton relaxivity. The SALI-functionalized Gd nano NU-1000 hybrid material displayed the highest loading of the Gd(III) complex (1.9 ± 0.1 complexes per node) and exhibited the most enhanced proton relaxivity (r1 of 26 ± 1 mM–1 s–1 at 1.4 T). Based on nuclear magnetic relaxation dispersion (NMRD) analysis, we can attribute the performance of Gd nano NU-1000 to the nanoscale size of the MOF particles and larger pore size that allows for rapid water exchange. We have demonstrated that SALI is a promising method for incorporating Gd(III) complexes into MOF materials and identified crucial design parameters for the preparation of next generation Gd(III)-functionalized MOF MRI contrast agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Metal-Organic Frameworks: Synthesis and Applications · Magnetism in coordination complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departments of Chemistry, Molecular Biosciences, Neurobiology, and Radiology, Northwestern University, Evanston, Illinois 60208, United States

International Institute of Nanotechnology, Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States

Magnetic Resonance Center (CERM), Consorzio Interuniversitario Risonanze Magnetiche di Metalloproteine (CIRMMP) and Department of Chemistry, University of Florence, 50019 Sesto Fiorentino, Italy

Funding

Air Force Research Laboratory · Ministero dell?Istruzione, dell?Universit? e della Ricerca · Division of Graduate Education · National Institute of Biomedical Imaging and Bioengineering · European Cooperation in Science and Technology · Office of Science · Northwestern University · Fondazione Cassa di Risparmio di Firenze

References (71)

Show source-provided references
1. 10.1152/physrev.00049.201010.1152/physrev.00049.2010 ↗
2. 10.1021/ar800245h10.1021/ar800245h ↗
3. 10.1021/cr400477t10.1021/cr400477t ↗
4. 10.1021/acs.jmedchem.5b0197510.1021/acs.jmedchem.5b01975 ↗
5. 10.1021/cr980440x10.1021/cr980440x ↗
6. 10.1039/b510982p10.1039/b510982p ↗
7. 10.1021/acs.chemrev.8b0036310.1021/acs.chemrev.8b00363 ↗
8. 10.1021/jacs.9b0914910.1021/jacs.9b09149 ↗
9. Helm L. · 2013
10. 10.1002/cmmi.26710.1002/cmmi.267 ↗
11. 10.1021/cr900232t10.1021/cr900232t ↗
12. 10.1155/2019/184563710.1155/2019/1845637 ↗
13. 10.1021/nn502986e10.1021/nn502986e ↗
14. 10.1021/acs.nanolett.6b0059910.1021/acs.nanolett.6b00599 ↗
15. 10.1021/acs.bioconjchem.6b0038910.1021/acs.bioconjchem.6b00389 ↗
16. 10.1039/C5CC06565H10.1039/C5CC06565H ↗
17. 10.1021/acs.bioconjchem.9b0064010.1021/acs.bioconjchem.9b00640 ↗
18. 10.1021/acsami.9b0354210.1021/acsami.9b03542 ↗
19. 10.1088/1361-6528/aaf44210.1088/1361-6528/aaf442 ↗
20. 10.1039/c3nr03762b10.1039/c3nr03762b ↗
21. 10.1021/bc200151q10.1021/bc200151q ↗
22. 10.1039/c2cs15229k10.1039/c2cs15229k ↗
23. Nandwana V. · Cancer Treat. Res. · 2015 · 166 · 5110.1007/978-3-319-16555-4_3 ↗
24. 10.1021/nl903264h10.1021/nl903264h ↗
25. 10.1021/acs.bioconjchem.8b0050410.1021/acs.bioconjchem.8b00504 ↗
26. 10.1038/nnano.2010.20310.1038/nnano.2010.203 ↗
27. 10.1021/nn507095310.1021/nn5070953 ↗
28. 10.1021/acs.nanolett.6b0337810.1021/acs.nanolett.6b03378 ↗
29. 10.1021/acs.jpcc.6b0836210.1021/acs.jpcc.6b08362 ↗
30. 10.1021/acsami.7b0963310.1021/acsami.7b09633 ↗
31. 10.1002/anie.20100486710.1002/anie.201004867 ↗
32. 10.1021/nn502393u10.1021/nn502393u ↗
33. 10.1039/C6SC00342G10.1039/C6SC00342G ↗
34. 10.1002/ejic.20180103910.1002/ejic.201801039 ↗
35. 10.1016/j.ccr.2009.05.01910.1016/j.ccr.2009.05.019 ↗
36. 10.1038/nchem.44410.1038/nchem.444 ↗
37. 10.1126/science.123044410.1126/science.1230444 ↗
38. 10.1039/C4CE01693A10.1039/C4CE01693A ↗
39. 10.1016/j.ccr.2015.08.00810.1016/j.ccr.2015.08.008 ↗
40. 10.1039/C8TA02132E10.1039/C8TA02132E ↗
41. 10.1021/ie101312k10.1021/ie101312k ↗
42. 10.1021/jacs.8b0208910.1021/jacs.8b02089 ↗
43. 10.1021/acsnano.7b0805610.1021/acsnano.7b08056 ↗
44. 10.1021/acsabm.8b0077810.1021/acsabm.8b00778 ↗
45. 10.1016/j.ccr.2019.02.03210.1016/j.ccr.2019.02.032 ↗
46. Markopoulou P. · 2020 · 24510.1016/B978-0-12-816984-1.00014-7 ↗
47. 10.1021/la900730b10.1021/la900730b ↗
48. 10.1021/am200075q10.1021/am200075q ↗
49. 10.1039/C8QI00149A10.1039/C8QI00149A ↗
50. 10.1021/ja409437810.1021/ja4094378 ↗
51. 10.1039/c3cc48562e10.1039/c3cc48562e ↗
52. 10.1038/nprot.2016.00110.1038/nprot.2016.001 ↗
53. 10.1039/C8CE00455B10.1039/C8CE00455B ↗
54. 10.1039/C5CC03398E10.1039/C5CC03398E ↗
55. 10.1039/C8CE01454J10.1039/C8CE01454J ↗
56. 10.1063/1.47987610.1063/1.479876 ↗
57. Kowalewski J. · Inorg. Chem. · 2005 · 57 · 41
58. 10.1016/j.ccr.2018.09.00910.1016/j.ccr.2018.09.009 ↗
59. 10.1021/acscentsci.8b0007310.1021/acscentsci.8b00073 ↗
60. 10.1039/C6CS00362A10.1039/C6CS00362A ↗
61. 10.1021/jacs.8b0678910.1021/jacs.8b06789 ↗
62. 10.1039/C5CS00837A10.1039/C5CS00837A ↗
63. 10.1021/acs.accounts.6b0057710.1021/acs.accounts.6b00577 ↗
64. 10.1021/acsami.8b0282510.1021/acsami.8b02825 ↗
65. 10.1021/acs.chemmater.0c0063410.1021/acs.chemmater.0c00634 ↗
66. 10.1016/S0010-8545(99)00237-410.1016/S0010-8545(99)00237-4 ↗
67. 10.1002/jmri.2196710.1002/jmri.21967 ↗
68. 10.1039/b719704g10.1039/b719704g ↗
69. 10.1038/s41467-019-09342-310.1038/s41467-019-09342-3 ↗
70. 10.1103/PhysRevB.81.10010110.1103/PhysRevB.81.100101 ↗
71. 10.1039/C8CE00992A10.1039/C8CE00992A ↗